← Eichor
Study identifier: NCT01789229 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Establishment of a Tumor Bank for Tissue Samples

Condition: Ovarian Neoplasms · Breast Neoplasms · Colorectal Neoplasms  ·  Sponsor: Medical University of Vienna

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank. This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".

This description comes directly from the study's public registry record.

Talk to the study team

Robert Zeillinger, Prof.Dr.  ·  +43140400  ·  robert.zeillinger@meduniwien.ac.at

Eva Obermayr, PhD  ·  +4340400  ·  eva.obermayr@muv.ac.at

Always discuss trial participation with your own doctor first.

Locations (3)

Medical University Vienna, Dptm. of Obstetrics & GynaecologyVienna, AustriaRecruiting
University Hospitals Leuven - Department of Obstetrics and GynaecologyLeuven, BelgiumCompleted
Charité University - Campus Virchow ChlinicBerlin, GermanyActive Not Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01789229